Morishima Y - Search Results

1

A dose-finding study of glycosylated G-CSF (Lenograstim) combined with CHOP therapy for stem cell mobilization in patients with non-Hodgkin's lymphoma.

Takeyama K, Ogura M, Morishima Y, Kasai M, Kiyama Y, Ohnishi K, Mitsuya H, Kawano F, Masaki Y, Sasaki T, Chou T, Yokozawa T, Tobinai K; Lenograstim/Lymphoma Study Group. Takeyama K, et al. Among authors: morishima y. Jpn J Clin Oncol. 2003 Feb;33(2):78-85. doi: 10.1093/jjco/hyg013. Jpn J Clin Oncol. 2003. PMID: 12629058 Clinical Trial.

2

Single institute experience of chemotherapy and adjuvant radiotherapy for localized aggressive non-Hodgkin's lymphoma: retrospective analysis of the clinical efficacy of radiation therapy.

Kodaira T, Fuwa N, Kamata M, Furutani K, Ogura M, Morishima Y. Kodaira T, et al. Among authors: morishima y. Am J Clin Oncol. 2002 Dec;25(6):612-8. doi: 10.1097/00000421-200212000-00018. Am J Clin Oncol. 2002. PMID: 12478011

3

Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients.

Oyama T, Ichimura K, Suzuki R, Suzumiya J, Ohshima K, Yatabe Y, Yokoi T, Kojima M, Kamiya Y, Taji H, Kagami Y, Ogura M, Saito H, Morishima Y, Nakamura S. Oyama T, et al. Among authors: morishima y. Am J Surg Pathol. 2003 Jan;27(1):16-26. doi: 10.1097/00000478-200301000-00003. Am J Surg Pathol. 2003. PMID: 12502924

4

Associations between polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and susceptibility to malignant lymphoma.

Hishida A, Matsuo K, Hamajima N, Ito H, Ogura M, Kagami Y, Taji H, Morishima Y, Emi N, Tajima K. Hishida A, et al. Among authors: morishima y. Haematologica. 2003 Feb;88(2):159-66. Haematologica. 2003. PMID: 12604405

5

Phenotypic analysis of peripheral T/NK cell lymphoma: study of 408 Japanese cases with special reference to their anatomical sites.

Ichimura K, Kagami Y, Suzuki R, Kojima M, Yoshino T, Ohshima K, Koike K, Kondo E, Taji H, Ogura M, Morishima Y, Akagi T, Takahashi T, Nakamura S. Ichimura K, et al. Among authors: morishima y. Pathol Int. 2003 Jun;53(6):333-44. doi: 10.1046/j.1440-1827.2003.01479.x. Pathol Int. 2003. PMID: 12787307

6

Pilot phase I/II study of new salvage therapy (CHASE) for refractory or relapsed malignant lymphoma.

Ogura M, Kagami Y, Taji H, Suzuki R, Miura K, Takeuchi T, Morishima Y. Ogura M, et al. Among authors: morishima y. Int J Hematol. 2003 Jun;77(5):503-11. doi: 10.1007/BF02986620. Int J Hematol. 2003. PMID: 12841390 Clinical Trial.

7

Polymorphism in the hMSH2 gene (gIVS 12-6T-->C) and risk of non-Hodgkin lymphoma in a Japanese population.

Hishida A, Matsuo K, Hamajima N, Ito H, Ogura M, Kagami Y, Taji H, Morishima Y, Emi N, Tajima K. Hishida A, et al. Among authors: morishima y. Cancer Genet Cytogenet. 2003 Nov;147(1):71-4. doi: 10.1016/s0165-4608(03)00185-7. Cancer Genet Cytogenet. 2003. PMID: 14580774

8

Polymorphisms of p53 Arg72Pro, p73 G4C14-to-A4T14 at exon 2 and p21 Ser31Arg and the risk of non-Hodgkin's lymphoma in Japanese.

Hishida A, Matsuo K, Tajima K, Ogura M, Kagami Y, Taji H, Morishima Y, Emi N, Naoe T, Hamajima N. Hishida A, et al. Among authors: morishima y. Leuk Lymphoma. 2004 May;45(5):957-64. doi: 10.1080/10428190310001638878. Leuk Lymphoma. 2004. PMID: 15291355

9

Efficacy and safety of imatinib mesylate for patients in the first chronic phase of chronic myeloid leukemia: results of a Japanese phase II clinical study.

Morishima Y, Ogura M, Nishimura M, Yazaki F, Bessho M, Mizoguchi H, Chiba S, Hirai H, Tauchi T, Urabe A, Takahashi M, Ohnishi K, Yokozawa T, Emi N, Hirano M, Shimazaki C, Nakao S, Kawai Y, Fujimoto M, Taguchi H, Jinnai I, Ohno R. Morishima Y, et al. Int J Hematol. 2004 Oct;80(3):261-6. doi: 10.1532/ijh97.04074. Int J Hematol. 2004. PMID: 15540902 Clinical Trial.

10

Durable response but prolonged cytopenia after cladribine treatment in relapsed patients with indolent non-Hodgkin's lymphomas: results of a Japanese phase II study.

Ogura M, Morishima Y, Kobayashi Y, Uike N, Sugai S, Chou T, Kasai M, Miura I, Murayama T, Matsuno Y, Nakamura S, Mori S, Ohashi Y, Tobinai K; Cladribine Study Group. Ogura M, et al. Among authors: morishima y. Int J Hematol. 2004 Oct;80(3):267-77. doi: 10.1532/ijh97.04077. Int J Hematol. 2004. PMID: 15540903 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

920 results

Search Page

Filters